Related Experiment Video
Updated: Jan 26, 2026
06:27
Identification of Mycobacterium Species by DNA Microarray Chip Method
Published on: June 24, 2025
549
A Two-Way Proteome Microarray Strategy to Identify Novel Mycobacterium tuberculosis-Human Interactors.
Tingming Cao1, Lingna Lyu1, Hongyan Jia1
1Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Frontiers in Cellular and Infection Microbiology
|April 16, 2019
Summary
Researchers identified 84 new human proteins interacting with Mycobacterium tuberculosis (Mtb), offering potential targets for tuberculosis diagnosis and treatment. This study advances understanding of Mtb pathogenesis.
Area of Science:
- Microbiology
- Immunology
- Proteomics
Background:
- Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a global health threat.
- Limited understanding of Mtb pathogenesis hinders TB elimination efforts.
- Identifying host-pathogen interactions is crucial for developing diagnostics and therapeutics.
Purpose of the Study:
- To systematically identify human proteins that interact with Mtb.
- To characterize the binding partners of Mtb effector proteins.
- To uncover novel molecular targets for TB intervention.
Main Methods:
- Utilized a comprehensive, two-way proteome microarray approach.
- Performed unbiased screening of global human Mtb interactors.
- Validated interactions using His-tagged pull-down assays and Co-immunoprecipitation (Co-IP).
Main Results:
- Identified 84 potential human Mtb interactors.
- Bioinformatic analysis indicated involvement in DNA transcription, necrosis, and immune signaling.
- Confirmed specific interactions: Rv0577 with NRF1, and Rv0577, Rv2117, Rv2423 with SMAD2.
Conclusions:
- Provides novel insights into Mtb-host protein interactions.
- Highlights potential molecular targets for TB diagnosis and treatment.
- Demonstrates a powerful strategy for discovering Mtb effectors and their binding partners.
Related Concept Videos
02:34DNA Microarrays
20.9K
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
20.9K
01:33Proteomics
9.5K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
9.5K
01:29Pulmonary Tuberculosis I
884
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
884
01:28Pulmonary Tuberculosis II
1.5K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.5K
01:28Pulmonary Tuberculosis V
564
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
564
01:31Pulmonary Tuberculosis III
1.0K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.0K